ExoRNA Bioscience Nanjing

ExoRNA Bioscience is a biotechnology company headquartered in Nanjing, China, focused on developing next-generation RNA therapeutics using proprietary exosome delivery technology. The company's platform addresses the critical challenge of targeted delivery for nucleic acid drugs, such as mRNA and siRNA, by leveraging the natural transport capabilities of exosomes. ExoRNA's pipeline primarily targets oncology and rare genetic diseases where traditional lipid nanoparticle delivery faces limitations. By engineering exosomes for high loading efficiency and tissue-specific tropism, the company aims to create safer and more effective RNA-based medicines.